August 2011 in “Clinical and Experimental Dermatology”
In this study, 30% of a diverse female sample reported experiencing what they perceived as excessive hairshedding, often beginning abruptly and without an attributable cause.
34 citations
,
May 2013 in “Journal of the European Academy of Dermatology and Venereology”
In this study, changes in hair cycle phases during pregnancy and the post-partum period showed a rise in telogen rates after delivery, especially among non-breastfeeding women, but no drastic exaggerations were noted.
1 citations
,
December 2015 in “International journal of pediatric research”
This review discusses the occurrence of hair tourniquets in children and adolescents, reporting no new clinical results but highlighting case variations by age and affected body part.
This case report describes the first known association between maternal telogen effluvium and hair-thread tourniquet syndrome in infants, suggesting that informing new parents about hair loss may prevent toe tourniquet syndrome.
9 citations
,
January 2015 in “Skin appendage disorders”
This review found no significant evidence supporting postpartum telogen effluvium as a distinct condition, suggesting its incidence is uncertain and possibly negligible.
High prolactin levels can cause hair loss, and finasteride may increase prolactin. Cabergoline or Vitamin B6 might lower prolactin, but combining them with finasteride requires caution.
Finasteride users may have an increased risk of depression, anxiety, and suicidal thoughts, though some attribute these issues to hair loss itself. The link between finasteride and mental health effects is debated, with varying user experiences.
Hair growth serums, specifically those with minoxidil and finasteride, are discussed as potential treatments for hair loss. The effectiveness of these serums is questioned, with a focus on whether they promote regrowth or merely prevent further loss.
Pregnancy can temporarily reverse hair loss in women, but attempts to mimic pregnancy hormones with treatments like contraceptive pills, spironolactone, estradiol, progesterone, finasteride, and minoxidil have been ineffective. The discussion highlights the need for research into the hormonal mechanisms of pregnancy that affect hair regrowth.
The user experienced significant hair regrowth after 2.5 years of using Minoxidil 5% and hormone replacement therapy (HRT) with Lupron, despite initial scalp irritation. Finasteride was ineffective for them.